Author:
Malysheva I. E.,Topchieva L. V.,Tikhonovich E. L.
Reference29 articles.
1. Sarbassov, D.D., Ali, S.M., Kim, D.H., et al., Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Curr. Biol., 2004, vol. 14, pp. 1296—1302. https://doi.org/10.1016/j.cub.2004.06.054
2. Huang, S., mTOR signaling in metabolism and cancer,Cells, 2020, vol. 9, no. 10. https://doi.org/10.3390/cells9102278
3. Linke, M., Pham, H.T., Katholnig, K., et al., Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression, Nat. Immunol., 2017, vol. 18, no. 3, pp. 293—302. https://doi.org/10.1038/ni.3655
4. Shmelev, E.I., Sarcoidosis, in Atmosfera, pul’monologiya i allergologiya (Atmosphere, Pulmonology, and Allergology), 2004, no. 2, pp. 3—10.
5. Malysheva, I.E., Tikhonovich, E.L., Oleinik, E.K., et al., Macrophage polarization in sarcoidosis, Med. Immunol., 2021, vol. 23, no. 1, pp. 7—16. https://doi.org/10.15789/1563-0625-MPI-2083